+91 22 24172311
Sections
Search
Subscribe
Equity
Venture Capital
Private Equity
M&A
Private Equity | 8 September 2010    9 Comment

Actis, Sequoia Plan Stake Sale In Paras Pharma For $700 Mn

by Deeshesh Chheda
 
@deeshesh

Private equity firms Actis Capital and Sequoia Capital are planning to sell a controlling stake in FMCG company @Paras_Pharmaceuticals Limited for $700 million.

The private equity firms decided to sell their shares after receiving interest from drugmakers including GlaxoSmithKline, Sanofi-Aventis and Abbott Laboratories.

Actis, a private equity firm that invests in emerging markets, holds about 62% in Paras and Sequoia holds about 8%, while Paras Chairman Girish Patel and employees own the remaining stake.

Transaction Reference: BS


Century Real Estate Raises Rs 100 Cr Via NCDs

Century Real Estate Holdings, the real estate arm of the Century Group has raised Rs.100 crore though private placement of NCDs last week.

Read More...

Nexus Venture Buys Stake In Startup Function Space

Pune based education startup Function Space has raised an undisclosed amount of funding in seed round from Nexus India Capital to strengthen its existing content and also increase its current userbase.

Read More...
TL Home Search New Keet
CONTACT US
Info@DealCurry.com
+91 22 24172311
A 311, 3rd Floor, AntopHill Warehousing Company,
Near Dosti Acres
Wadala(E),
Mumbai 400037
   
 
CLIENTS
USEFUL LINKS
SOLUTIONS
Copyright © EagleEye Research & Media Pvt. Ltd. 2009 All Rights Reserved - Interactive multimedia analysis platform for financial markets.
Site map |Terms of Use |Privacy Policy
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.